The diagnostic utility of autoantibodies in adult and juvenile myositis

Sarah L. Tansley, Zoe E. Betteridge, Neil J. Mchugh

Research output: Contribution to journalArticlepeer-review

49 Citations (SciVal)


Purpose of review: The purpose of this study is to review recent advances in the diagnostic utility of autoantibodies in dermatomyositis.

Recent findings: Alternative nonspecialist testing methods have been developed for anti-transcription intermediary factor 1 gamma, anti-MDA5 and anti-nuclear matrix protein 2, which are potentially exploitable by any hospital laboratory. Although these have yet to be validated for diagnostic use, it is likely that testing for myositis-specific antibodies will soon become readily available.

Summary: The identification of myositis-specific autoantibodies provides both diagnostic and prognostic information and offers a unique opportunity to adopt a stratified approach to treatment. Their identification, in many cases, should prevent the need for invasive diagnostic tests such as muscle biopsy.
Original languageEnglish
Pages (from-to)772-777
Number of pages6
JournalCurrent Opinion in Rheumatology
Issue number6
Publication statusPublished - Nov 2013


Dive into the research topics of 'The diagnostic utility of autoantibodies in adult and juvenile myositis'. Together they form a unique fingerprint.

Cite this